Login / Signup

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma.

Monika BaudenTheresa KristlAgata SasorBodil AnderssonGyörgy Marko-VargaRoland AnderssonDaniel Ansari
Published in: BMC cancer (2017)
We suggest that the intratumor histone H1.3 expression as reported herein, may serve as a new epigenetic biomarker for PDAC.
Keyphrases
  • dna methylation
  • poor prognosis
  • gene expression
  • binding protein
  • long non coding rna